Improving the Management of COPD in Women.

COPD is a highly debilitating disease that represents a substantial and growing health burden in women. There is increasing evidence for sex-related differences in COPD risk, progression, and outcomes. However, the disease receives scant attention as a women's health issue. Thus, a multifaceted approach is required to address COPD in women, including greater awareness, minimization of risk, and further elucidation of the sex-specific factors (biological and cultural) that affect risk, disease progression, and treatment success. This article reviews the current literature on the topic and provides suggestions for achieving better outcomes for the millions of women with COPD worldwide.

• Publication year

  2017

• Venue

  Chest

• Publication date

  2017-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.chest.2016.10.031PMID 27816445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence and etiological profile of chronic obstructive pulmonary disease in nonsmokers

  2017influential reference
• Predictors of All-Cause Mortality in Patients With Severe COPD and Major Depression Admitted to a Rehabilitation Hospital.

  2016cited by this paper
• Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study

  2015cited by this paper
• Respiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment Test

  2015cited by this paper
• Sex-specific features of emphysema among current and former smokers with COPD

  2015cited by this paper
• Prevalence of different comorbidities in COPD patients by gender and GOLD stage

  2015influential reference
• Is a previous diagnosis of asthma a reliable criterion for asthma–COPD overlap syndrome in a patient with COPD?

  2015cited by this paper
• Global and regional trends in COPD mortality, 1990–2010

  2015cited by this paper
• Socioeconomic inequalities in non-communicable diseases and their risk factors: an overview of systematic reviews

  2015cited by this paper
• Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease

  2015cited by this paper
• Tuberculosis and chronic respiratory disease: a systematic review.

  2015cited by this paper
• Clinical characteristics and quality of life in women with COPD: an observational study

  2014influential reference
• Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke.

  2014cited by this paper
• Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis.

  2014cited by this paper
• Gender-Associated Differences in Pulmonary Rehabilitation Outcomes in People With Chronic Obstructive Pulmonary Disease: A SYSTEMATIC REVIEW

  2014cited by this paper
• The “other” COPD

  2014cited by this paper
• Impact of gender on COPD expression in a real-life cohort

  2014cited by this paper
• Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke.

  2014cited by this paper
• Sex discrepancies in COPD patients and burden of the disease in females: a nationwide study in Greece (Greek Obstructive Lung Disease Epidemiology and health ecoNomics: GOLDEN study)

  2014cited by this paper
• Respiratory risks from household air pollution in low and middle income countries.

  2014cited by this paper
• Primary Care COPD Patients Compared with Large Pharmaceutically-Sponsored COPD Studies: An UNLOCK Validation Study

  2014cited by this paper
• Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes

  2014cited by this paper
• Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials.

  2014cited by this paper
• Smoking trends among women in India: Analysis of nationally representative surveys (1993–2009)

  2014cited by this paper
• Infradiagnóstico de la enfermedad pulmonar obstructiva crónica en mujeres: cuantificación del problema, determinantes y propuestas de acción

  2013cited by this paper
• Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial

  2013influential reference
• COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women

  2013cited by this paper
• Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study

  2013cited by this paper
• Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions.

  2013influential reference
• Epidemiology of chronic obstructive pulmonary disease: a literature review

  2012cited by this paper
• Comorbidity and Sex-Related Differences in Mortality in Oxygen-Dependent Chronic Obstructive Pulmonary Disease

  2012cited by this paper
• Impairment of quality of life in women with chronic obstructive pulmonary disease.

  2012cited by this paper
• Morbidity and Mortality Weekly Report

  2012cited by this paper
• Sex, susceptibility to smoking and chronic obstructive pulmonary disease: the effect of different diagnostic criteria. Analysis of the Health Survey for England

  2012cited by this paper
• Gender Differences in Symptoms and Care Delivery for Chronic Obstructive Pulmonary Disease

  2012influential reference
• Secondhand smoke exposure predicted COPD and other tobacco-related mortality in a 17-year cohort study in China.

  2012cited by this paper
• Chronic Obstructive Pulmonary Disease and SocioEconomic Status: a Systematic Review

  2012cited by this paper
• Gender empowerment and female-to-male smoking prevalence ratios.

  2011cited by this paper
• Chronic obstructive pulmonary disease: Does gender really matter?

  2011cited by this paper
• Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes.

  2011influential reference
• Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study.

  2011cited by this paper
• Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma.

  2011cited by this paper
• Tobacco Use and Cessation Among Women: Research and Treatment-Related Issues

  2011cited by this paper
• Gender, Women and the Tobacco Epidemic

  2011cited by this paper
• Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration

  2011cited by this paper
• Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience.

  2010cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions

  2010cited by this paper
• Gender differences in COPD: are women more susceptible to smoking effects than men?

  2010cited by this paper
• Publication

  2010cited by this paper
• Characterisation of COPD heterogeneity in the ECLIPSE cohort

  2010cited by this paper
• Gender differences in predictors of health status in patients with COPD.

  2010influential reference
• Gender differences in survival following hospitalisation for COPD

  2010cited by this paper
• Characteristics of chronic obstructive pulmonary disease in Spain from a gender perspective

  2009influential reference
• Sex differences in emphysema and airway disease in smokers.

  2009cited by this paper
• Sex differences in mortality in patients with COPD

  2009cited by this paper
• Trends in COPD prevalence and exacerbation rates in Dutch primary care.

  2009cited by this paper
• Real-World Clinical Data Identifies Gender-related Profiles in Chronic Obstructive Pulmonary Disease

  2009cited by this paper
• Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis

  2009cited by this paper
• Depression and health-related quality of life in chronic obstructive pulmonary disease.

  2009cited by this paper
• Chronic obstructive pulmonary disease in non-smokers

  2009influential reference
• Female and male chronic obstructive pulmonary disease patients with severe dyspnea do not profit less from pulmonary rehabilitation.

  2008cited by this paper
• Occupational exposures and the risk of COPD: dusty trades revisited

  2008cited by this paper
• A study on health status of women engaged in a home-based “Papad-making” industry in a slum area of Kolkata

  2008influential reference
• Gender and chronic obstructive pulmonary disease: why it matters.

  2007influential reference
• The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism.

  2007cited by this paper
• Neurological Disorders: Public Health Challenges

  2007cited by this paper
• Sex differences in severe pulmonary emphysema.

  2007cited by this paper
• Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial

  2006cited by this paper
• Examining the role of gender in health-related quality of life: Perceptions of older adults with chronic obstructive pulmonary disease.

  2006influential reference
• Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the Nordic countries.

  2006cited by this paper
• Anxiety and depression in COPD patients: The roles of gender and disease severity.

  2006cited by this paper
• Gender differences in the performance of activities of daily living among patients with chronic obstructive pulmonary disease

  2006cited by this paper
• Gender difference in coping strategies among patients enrolled in an inpatient rehabilitation program.

  2006cited by this paper
• Projections of Global Mortality and Burden of Disease from 2002 to 2030

  2006cited by this paper
• Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco.

  2006cited by this paper
• Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

  2006cited by this paper
• Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial

  2006cited by this paper
• Gender and COPD in patients attending a pulmonary clinic.

  2006cited by this paper
• Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbation.

  2005cited by this paper
• Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

  2004cited by this paper
• Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease.

  2004cited by this paper
• Gender bias in the diagnosis of personality disorders: the roles of base rates and social stereotypes.

  2003cited by this paper
• Changes in smoking status affect women more than men: results of the Lung Health Study.

  2003cited by this paper
• Inhaled corticosteroids and hip fracture: a population-based case-control study.

  2002cited by this paper
• Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study

  2002cited by this paper
• Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.

  2002cited by this paper
• Chronic obstructive pulmonary disease.

  2002cited by this paper
• The use of the Hospital Anxiety and Depression Scale (HADS) in patients with chronic obstructive pulmonary disease: a pilot study.

  2001cited by this paper
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary.

  2001cited by this paper
• Gender bias in the diagnosis of COPD.

  2001influential reference
• Gender moderates the effects of exercise therapy on health-related quality of life among COPD patients.

  2001cited by this paper
• Chronic obstructive pulmonary disease.

  2000cited by this paper
• Gender differences in airway behaviour over the human life span

  1999cited by this paper
• Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study.

  1997cited by this paper
• Is bronchial hyperresponsiveness more frequent in women than in men? A population-based study.

  1997cited by this paper
• Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group.

  1996cited by this paper
• The influence of age, diagnosis, and gender on proper use of metered-dose inhalers.

  1994cited by this paper

• Navigating COPD and Bronchiectasis: A COPD Foundation 360Social Survey of Health Care Experiences and Perceptions.

  2025cites this paper
• Sex, hormones, and lung health.

  2025cites this paper
• Addressing Sex as a Biological Variable in Preclinical Models of Lung Disease: An Official American Thoracic Society Research Statement

  2025cites this paper
• Evaluation of the effectiveness of om-85 bv combination therapy in chronic obstructive pulmonary disease at Bai Chay Hospital, 2024 – 2025

  2025cites this paper
• Global, Regional, and National Burden of COPD Among Women from 1990 to 2021 and Projections to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021

  2025cites this paper
• Perceived Access, Perceived Need for Treatment, and the Decision to Seek Care for COPD Exacerbations.

  2025cites this paper
• [Improving the quality of COPD treatment by bundled payment method: lessons from a national pilot program].

  2025cites this paper
• The importance of translational science within the respiratory field

  2024cites this paper
• Clinical factors associated with smoking cessation among smokers with Chronic Obstructive Pulmonary Disease by sex: Longitudinal analyses from French smoking cessation services

  2024cites this paper
• Development and validation of a new algorithm for improved cardiovascular risk prediction

  2024cites this paper
• Prevalence and disparities in influenza vaccination among patients with COPD: A French nationwide population study.

  2024cites this paper
• Being met as a person and not as a diagnosis – Meanings of healthcare encounters for women with chronic obstructive pulmonary disease stage III or IV

  2024cites this paper
• Maximum Phonation Times as Biomarkers of Lung Function.

  2024cites this paper
• Patient Sex and Physician Gender as Modifiers of Low-density Lipoprotein Cholesterol Control in High-risk Patients of Atherosclerotic Disease: A Cross-sectional Study

  2024cites this paper
• [Clinical and prognostic differences in chronic obstructive pulmonary disease in women referred to respiratory rehabilitation: A gendered view].

  2024cites this paper
• [Real-life utilization of fixed triple therapy in COPD: The Trilife study. Beclomethasone/formoterol/glycopyrronium triple fixed-dose therapy in extra-fine particles].

  2024cites this paper
• Awareness of COPD in low-and middle-income countries and implications for treatment

  2024cites this paper
• Sex Differences in Impacts of Early Gestational and Peri-Adolescent Ozone Exposure on Lung Development in Rats: Implications for Later Life Disease in Humans.

  2024cites this paper
• Management Reality of Female Patients with COPD: A Multicenter Cross-Sectional CAP Study in Japan

  2024cites this paper
• Palliative Care Interventions in Advanced Chronic Obstructive Pulmonary Disease: An Integrative Review

  2023cites this paper
• Use FEV1/FVC Z-Score Staging to Minimize Sex and Age Bias in Staging Chronic Obstructive Pulmonary Disease

  2023cites this paper
• Differences in chronic obstructive pulmonary disease among US nursing home residents with heart failure according to sex and type of heart failure

  2023cites this paper
• Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada

  2023cites this paper
• Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium

  2023cites this paper
• Gender-specific disease trajectories prior to the onset of COPD allow individualized screening and early intervention

  2023cites this paper
• Improvements in health status with revefenacin, a once-daily, nebulized, long-acting muscarinic antagonist for chronic obstructive pulmonary disease.

  2023cites this paper
• Care-seeking and delay of care during COPD exacerbations

  2022cites this paper
• Obesity Pillars Roundtable: Body mass index and body composition in Black and Female individuals. Race-relevant or racist? Sex-relevant or sexist?

  2022cites this paper
• Sex differences in adult asthma and COPD therapy: a systematic review

  2022cites this paper
• Sex Differences in Airways at Chest CT: Results from the COPDGene Cohort.

  2022cites this paper
• Childhood ‘bronchitis’ and respiratory outcomes in middle-age: a prospective cohort study from age 7 to 53 years

  2022cites this paper
• Race and Sex Differences in Mortality in Individuals with Chronic Obstructive Pulmonary Disease.

  2022cites this paper
• Assessment of Quality of life in Home versus Hospital Based Pulmonary Rehabilitation in COPD Patients: A Comparative Study

  2022cites this paper
• Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET

  2022cites this paper
• Geographic Differences in Sex-Specific Chronic Obstructive Pulmonary Disease Mortality Rate Trends Among Adults Aged ≥25 Years — United States, 1999–2019

  2022cites this paper
• Predictors of chronic obstructive pulmonary disease in women who have never smoked: a cohort study

  2022cites this paper
• Avaliação das diferenças nas manifestações clínicas da doença pulmonar obstrutiva crônica entre homens e mulheres: um estudo transversal analítico

  2022cites this paper
• Time Trends (2012–2020), Sex Differences and Predictors for Influenza Vaccination Uptake among Individuals with Chronic Obstructive Pulmonary Disease in Spain

  2022cites this paper
• Women's COPD

  2022cites this paper
• Sex Differences in Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Cambios en la tolerancia al ejercicio, disnea y calidad de vida a las 8 vs. 12 semanas de rehabilitación pulmonar en pacientes con EPOC

  2021cites this paper
• An Update in Health Disparities in COPD in the USA

  2021cites this paper
• Ambient air pollution exposure and chronic bronchitis in the Lifelines cohort

  2021cites this paper
• Malnutrition According to GLIM Criteria Is Associated with Mortality and Hospitalizations in Rehabilitation Patients with Stable Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Transitions between COPD groups: A cross-sectional study in Turkey.

  2021cites this paper
• Sex differences in COPD management

  2021cites this paper
• Underestimation of respiratory symptoms by smokers: a thorn in chronic obstructive pulmonary disease diagnosis

  2021cites this paper
• Sex Steroids and Their Influence in Lung Diseases Across the Lifespan

  2021cites this paper
• The information needs of people with COPD—The holistic approach with special reference to gender and time since diagnosis

  2021cites this paper
• INVITED REVIEW SERIES: COPD: NEW HORIZONS SERIES EDITORS: CHRISTINE JENKINS AND PASCAL CHANEZ Contemporary perspectives in COPD: Patient burden, the role of gender and trajectories of multimorbidity

  2021cites this paper
• The Perception of Physicians on Gender-Specific Differences in the Diagnosis of COPD: Results from a Questionnaire-Based Survey

  2021influential citation
• Trends in Hospital Admissions for Chronic Obstructive Pulmonary Disease in Men and Women in Spain, 1998 to 2018

  2021influential citation
• Dyspnoea and symptom burden in mild–moderate COPD: the Canadian Cohort Obstructive Lung Disease Study

  2021cites this paper
• Respiratory diseases: Sex and gender evidence in obstructive sleep apnea, chronic obstructive pulmonary disease, and asthma

  2021cites this paper
• Sex and Gender Differences in Lung Disease.

  2021cites this paper
• Common Mental Disorders, Functional Limitation and Diet Quality Trends and Related Factors among COPD Patients in Spain, 2006–2017: Evidence from Spanish National Health Surveys

  2021cites this paper
• Pharmacology Considerations in Women in Lung Disease and Critical Care.

  2021cites this paper
• Diffusing Capacity, the Too Often Ignored Lung Function Test in COPD.

  2021cites this paper
• Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD

  2021cites this paper
• Outcomes of Patients with COPD Hospitalized for Coronavirus Disease 2019.

  2021cites this paper
• Access to pulmonary rehabilitation services around the world

  2021cites this paper
• Right ventricular end‐diastolic volume and outcomes in exacerbations of COPD

  2021cites this paper
• Air Pollution Exposure as a Relevant Risk Factor for COPD Exacerbations in Male and Female Patients

  2021cites this paper
• COPD_A_271505 901..907

  2021influential citation
• Examination of Periodontal Status in Chronic Obstructive Pulmonary Disease Greek Adults: A Case - Control Study

  2020cites this paper
• Cardiovascular Comorbidity in Chronic Lung Disease: Gender Differences

  2020cites this paper
• Social Profile of Patients Admitted for COPD Exacerbations. A Gender Analysis.

  2020cites this paper
• Medication adherence among patients with chronic obstructive pulmonary disease treated in a primary general hospital during the COVID-19 pandemic

  2020cites this paper
• Deciphering patterns of respiratory medication use in Ireland to target interventions appropriately: a focus on COPD

  2020cites this paper
• Sex-specific associations with DNA methylation in lung tissue demonstrate smoking interactions

  2020cites this paper
• Lung cancer in women in 21th century

  2020cites this paper
• Amerindian Ancestry Influences Genetic Susceptibility to Chronic Obstructive Pulmonary Disease

  2020cites this paper
• Dependent lesion positioning at CT-guided lung biopsy to reduce risk of pneumothorax

  2020influential citation
• Patient Activation Among Community-Dwelling Persons Living with Chronic Obstructive Pulmonary Disease.

  2020cites this paper
• Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy

  2020cites this paper
• Social Profile of Patients Admitted for COPD Exacerbations. A Gender Analysis

  2020cites this paper
• Impact of gender on chronic obstructive pulmonary disease outcomes: a propensity score-matched analysis of a prospective cohort study

  2020cites this paper
• COPD_A_240303 995..1004

  2020cites this paper
• COPD_A_237228 711..721

  2020cites this paper
• Enhancing Confidence and Coping with Stigma in an Ambiguous Interaction with Primary Care: A Qualitative Study of People with COPD

  2020cites this paper
• Modulation of the lung inflammatory response to ozone by the estrous cycle

  2019cites this paper
• COPD_A_217921 2469..2478

  2019cites this paper
• Gender differences among Swedish COPD patients: results from the ARCTIC, a real-world retrospective cohort study

  2019cites this paper
• Clinical Features Of Women With COPD: Sex Differences In A Cross-Sectional Study In Spain (“The ESPIRAL-ES Study”)

  2019cites this paper
• Pulmonary lipid homeostasis in cigarette smoke-associated lung diseases

  2019cites this paper
• [Vulnerability of women to tobacco: The broncho-pulmonary consequences (asthma, COPD)].

  2019cites this paper
• Gender Differences in Chronic Obstructive Pulmonary Disease Using the Lung Information Needs Questionnaire

  2019cites this paper
• What matters to people with COPD: outputs from Working Together for Change

  2019cites this paper
• Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT

  2019cites this paper
• Factors Associated With High-Quality Guidelines for the Pharmacologic Management of Chronic Diseases in Primary Care: A Systematic Review

  2019cites this paper
• Malnutrition according to ESPEN consensus predicts hospitalizations and long-term mortality in rehabilitation patients with stable chronic obstructive pulmonary disease.

  2019cites this paper
• Dynamic changes in lung responses after single and repeated exposures to cigarette smoke in mice

  2019cites this paper
• Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee

  2019cites this paper
• Facteurs étiologiques et épidémiologie des bronchopneumopathies chroniques obstructives (BPCO)

  2019cites this paper
• Treatment response to indacaterol/glycopyrronium versus salmeterol/fluticasone in exacerbating COPD patients by gender: a post-hoc analysis in the FLAME study

  2019cites this paper
• Association of cardiovascular and musculoskeletal biomarkers with clinical outcomes in chronic obstructive pulmonary disease.

  2019cites this paper
• Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate

  2019cites this paper
• Efficacy of aclidinium/formoterol 400/12 µ g, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of aClIFOrM and aUgMenT

  2019cites this paper
• Relationship between gender and survival in a real-life cohort of patients with COPD

  2019cites this paper
• Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.

  2019cites this paper